Pin OM-M 25 Tablet ER
By Pin OM-M
Rx
10 Tablet ER in a Strip

Composition
Olmesartan Medoxomil(20mg) + Metoprolol Succinate(25mg)

Manufacturer - Lupin Ltd
Lupin Ltd, 3rd floor Kalpataru Inspire, Off. W E Highway, Santacruz (East), Mumbai 400 055. India

Expires on or after
September, 2026
About Pin OM-M 25 Tablet ER
Pin OM-M 25 Tablet ER is a medication specifically designed to address high blood pressure issues in individuals. This medicine works by reducing blood pressure levels, ultimately aiding in the prevention of potential heart attacks and strokes. Ensuring the timely consumption of Pin OM-M 25 Tablet ER with food at a fixed daily schedule is essential to maintain consistent medication levels in the bloodstream. It is crucial to adhere to your doctor's guidance regarding the duration of intake, even if you feel well, as high blood pressure often presents without noticeable symptoms. Abruptly discontinuing this medication without medical advice may exacerbate your condition. Additionally, engaging in regular physical activity, maintaining a healthy weight, and following a balanced diet can contribute to effectively managing your blood pressure levels in conjunction with Pin OM-M 25 Tablet ER.
Common side effects associated with Pin OM-M 25 Tablet ER include nausea, diarrhea, headaches, decreased blood pressure, weakness, and elevated potassium levels in the blood. To mitigate potential adverse effects, it is advisable to avoid potassium-rich foods and supplements while taking this medication. Furthermore, individuals consuming Pin OM-M 25 Tablet ER should exercise caution while performing activities that require focus and balance due to the possibility of dizziness. Regular monitoring of blood pressure, blood sugar levels, kidney function, urea levels, and electrolyte levels during treatment is recommended to ensure the medication's efficacy and identify any potential complications promptly.
Prior to commencing treatment with Pin OM-M 25 Tablet ER, it is imperative to inform your healthcare provider about any existing liver or kidney conditions. Pregnant or breastfeeding individuals should seek medical advice before initiating this medication. Disclosing all concurrent medications, particularly those targeting high blood pressure or heart-related issues, is crucial for safe and effective treatment. Pin OM-M 25 Tablet ER represents a combination of Olmesartan, an angiotensin receptor blocker, and Metoprolol, a beta-blocker, both of which play a vital role in lowering elevated blood pressure levels in patients. Olmesartan functions by blocking angiotensin hormones, thereby promoting blood vessel relaxation and enhancing blood flow efficiency, while Metoprolol aids in reducing blood pressure by inhibiting certain natural substances in the body. The synergistic action of these components contributes to effectively managing blood pressure and diminishing the risk of heart diseases and strokes. It is essential to adhere to the prescribed dosage regimen for optimal therapeutic outcomes.
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹221.5
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024